FDA provides update on status of postmarketing reports and commitments
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyPharmaceuticalsPharmacovigilanceProject managementRegulatory Intelligence/PolicyRisk managementUnited States